| Product NDC: | 65862-292 |
| Proprietary Name: | Metformin Hydrochloride |
| Non Proprietary Name: | Metformin Hydrochloride |
| Active Ingredient(s): | 750 mg/1 & nbsp; Metformin Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-292 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079118 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120720 |
| Package NDC: | 65862-292-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-292-01) |
| NDC Code | 65862-292-01 |
| Proprietary Name | Metformin Hydrochloride |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-292-01) |
| Product NDC | 65862-292 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metformin Hydrochloride |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120720 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | METFORMIN HYDROCHLORIDE |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Biguanide [EPC],Biguanides [Chemical/Ingredient] |